These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7921730)

  • 41. [Pharmacologic approach to negative symptoms in schizophrenia].
    Jalenques I
    Encephale; 1995 Jun; 21 Spec No 3():35-40. PubMed ID: 7628340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ICI 204,636: a new atypical antipsychotic drug.
    Hirsch SR; Link CG; Goldstein JM; Arvanitis LA
    Br J Psychiatry Suppl; 1996 May; (29):45-56. PubMed ID: 8733823
    [No Abstract]   [Full Text] [Related]  

  • 43. Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia.
    Usall J; López-Carrilero R; Iniesta R; Roca M; Caballero M; Rodriguez-Jimenez R; Oliveira C; Bernardo M; Corripio I; Sindreu SD; González Piqueras JC; Felipe AE; Fernandez de Corres B; Ibáñez A; Huerta R;
    J Clin Psychiatry; 2014 Jun; 75(6):608-15. PubMed ID: 25004184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of negative symptoms in schizophrenia by amisulpride. Review of the literature].
    Pélissolo A; Krebs MO; Olié JP
    Encephale; 1996; 22(3):215-9. PubMed ID: 8767050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Add-on fluvoxamine and negative symptoms of schizophrenia: analysis of data from augmentation studies in a single center.
    Silver H; Bilker WB
    J Clin Psychopharmacol; 2013 Oct; 33(5):710-1. PubMed ID: 23899641
    [No Abstract]   [Full Text] [Related]  

  • 46. Do neuroleptics cause depression?
    Roy A
    Biol Psychiatry; 1984 May; 19(5):777-81. PubMed ID: 6145454
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nemonapride for the treatment of schizophrenia.
    Satoh K; Someya T; Shibasaki M
    Am J Psychiatry; 1997 Feb; 154(2):292. PubMed ID: 9016292
    [No Abstract]   [Full Text] [Related]  

  • 48. Cyproheptadine in treatment-resistant chronic schizophrenics with prior negative response to fluoxetine.
    Bacher NM; Sanzone MM; Kaup B
    J Clin Psychopharmacol; 1994 Dec; 14(6):424-5. PubMed ID: 7884024
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical profile of an atypical antipsychotic: risperidone.
    Davis JM; Chen N
    Schizophr Bull; 2002; 28(1):43-61. PubMed ID: 12047021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms.
    Abi-Saab W; Seibyl JP; D'Souza DC; Karper LP; Gueorgueva R; Abi-Dargham A; Wong ML; Rajhans S; Erdos JP; Heninger GR; Charney DS; Krystal JH
    Psychopharmacology (Berl); 2002 Jun; 162(1):55-62. PubMed ID: 12107618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clozapine augmented with aripiprazole in 5 patients with schizophrenia.
    Abu-Tair F; Kopitz J; Bergemann N
    J Clin Psychopharmacol; 2006 Dec; 26(6):669-71. PubMed ID: 17110831
    [No Abstract]   [Full Text] [Related]  

  • 52. Bupropion for depression in schizophrenia.
    Englisch S; Inta D; Eer A; Zink M
    Clin Neuropharmacol; 2010; 33(5):257-9. PubMed ID: 20852411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A discriminant validity study of negative symptoms with a special focus on depression and antipsychotic medication.
    Lewine RR
    Am J Psychiatry; 1990 Nov; 147(11):1463-6. PubMed ID: 1977328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Diagnostic principles for differential therapy of psychoses].
    Hell D; Bridler R
    Praxis (Bern 1994); 2001 May; 90(22):975-80. PubMed ID: 11450185
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New drug offers hope for people with schizophrenia.
    J Psychosoc Nurs Ment Health Serv; 1994 May; 32(5):46. PubMed ID: 7519676
    [No Abstract]   [Full Text] [Related]  

  • 56. Risperidone response after no clozapine response.
    Avnon M; Kunin A
    Br J Psychiatry; 1995 Nov; 167(5):699. PubMed ID: 8564340
    [No Abstract]   [Full Text] [Related]  

  • 57. [Depressive symptoms and biogenic amines as predictors of treatment response in schizophrenic illnesses in childhood and adolescence].
    Fleischhaker C; Schulz E; Remschmidt H
    Z Kinder Jugendpsychiatr Psychother; 1998 Dec; 26(4):235-43. PubMed ID: 9880833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Statistical differentiation between direct and indirect effects of neuroleptics on negative symptoms.
    Möller HJ; Müller H
    Eur Arch Psychiatry Clin Neurosci; 1997; 247(1):1-5. PubMed ID: 9088799
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measurement of depression and negative symptoms in schizophrenia.
    Goldman RS; Tandon R; Liberzon I; Greden JF
    Psychopathology; 1992; 25(1):49-56. PubMed ID: 1351305
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Negative symptoms of schizophrenia: a problem that will not go away.
    Stahl SM; Buckley PF
    Acta Psychiatr Scand; 2007 Jan; 115(1):4-11. PubMed ID: 17201860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.